As of December 2024, Jazz Pharmaceuticals has a market cap of $6.90B. This makes Jazz Pharmaceuticals the world's 2173th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $7.91B | 2.16% |
2023 | $7.74B | -22.79% |
2022 | $10.03B | 25.05% |
2021 | $8.02B | -22.81% |
2020 | $10.39B | 10.56% |
2019 | $9.40B | 20.43% |
2018 | $7.80B | -7.94% |
2017 | $8.48B | 23.50% |
2016 | $6.86B | -22.43% |
2015 | $8.85B | -14.15% |
2014 | $10.31B | 29.37% |
2013 | $7.97B | 137.67% |
2012 | $3.35B | 37.85% |
2011 | $2.43B | 96.29% |
2010 | $1.24B | 149.75% |
2009 | $496.10M | 308.29% |
2008 | $121.51M | -86.87% |
2007 | $925.47M | - |